Delapril hydrochloride

This classification denotes an ace inhibitor with the molecular formula C26H32N2O5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2SMM3M5ZMH, chemically known as glycine, n-(2,3-dihydro-1h-inden-2-yl)-n-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-, monohydrochloride, (s)- but more generally known as delapril hydrochloride, which bears US NIH Compound Identifier 5362115. European Medicines Agency schedules Delapril hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01574MIG. Most nations, for tariff and trade purposes, schedule delapril hydrochloride under HS 29242995 and SITC 51479. As of Q4 2014, DELAPRIL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Delapril hydrochloride bears US NLM identifiers UMLS ID C2348090 and NCI Concept Code C72734. SMILES: CCOC(=O)[C@H](CCC1CCCCC1)N[C@@H](C)C(=O)N(CC(=O)O)C2CC3CCCCC3C2.CL.